Analysts Offer Insights on Healthcare Companies: Sumitomo Dainippon Pharma Co (OtherDNPUF) and Sanofi (OtherSNYNF)
Analysts fell to the sidelines weighing in on Sumitomo Dainippon Pharma Co (DNPUF – Research Report) and Sanofi (SNYNF – Research Report) with ...
pharmaphorum5d
Exscientia starts trials of AI-designed Alzheimer's drug
The new molecule – called DSP-0038 – is being developed by Japan's Sumitomo Dainippon Pharma (DSP), which is now starting a phase 1 trial in the US as a treatment for psychosis associated with ...
pharmaphorum18d
Exscientia claims world first as AI-created drug enters clinic
UK-based Exscientia has been working with Japanese pharma Sumitomo Dainippon Pharma (DSP) on the drug for obsessive-compulsive disorder (OCD), and the trial aims to measure its efficacy.
Jefferies lifts Sumitomo Pharma stock rating to Buy, targets JPY900
Sumitomo Pharma shares received an improved outlook from Jefferies as analyst Stephen Barker upgraded the company's stock rating from Hold to Buy, accompanied by a price target increase to JPY900 from ...